Document:

f10k2008ex4vi_cybra.htm

    NEITHER
THESE SECURITIES NOR THE SECURITIES FOR WHICH THESE SECURITIES ARE EXERCISABLE
HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE
SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM
REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES
ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN
EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN
AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION
REQUIREMENTS OF THE SECURITIES ACT AND IN COMPLIANCE WITH APPLICABLE STATE
SECURITIES OR BLUE SKY LAWS.  THESE SECURITIES AND THE SECURITIES
ISSUABLE UPON EXERCISE OF THESE SECURITIES MAY BE PLEDGED IN CONNECTION WITH A
BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES.

     

    

     

    CYBRA
CORPORATION

     

    WARRANT

     

    Warrant
No. B--__ (2007 Series) Dated:  _________ __, 200_

     

    CYBRA
Corporation, a New York corporation (the “Company”), hereby certifies
that, for value received, ________________________ or its registered assigns
(the “Holder”), is
entitled to purchase from the Company up to a total of _____________________
shares of common stock, $0.001 par value per share (the “Common Stock”), of the Company
(each such share, a “Warrant
Share” and all such shares, the “Warrant Shares”) at an
exercise price equal to $1.75 per share (as adjusted from time to time as
provided in Section
9, the “Exercise
Price”), at any time and from time to time from and after the date hereof
and through and including the date that is five years from the date of issuance
hereof (the “Expiration
Date”), and subject to the following terms and
conditions.  This Warrant (this “Warrant”) is one of a series
of similar warrants issued in connection with a private placement offering of
Common Stock to a limited number of investors and has been issued pursuant to a
Securities Purchase Agreement, dated as of the date hereof, by and between the
Company and the Holder (the “Purchase
Agreement”).  All such warrants are referred to herein,
collectively, as the “Warrants.”

     

    1. Definitions.  In
addition to the terms defined elsewhere in this Warrant, capitalized terms that
are not otherwise defined herein have the meanings given to such terms in the
Purchase Agreement.

     

    2. Registration of
Warrant.  The Company shall register this Warrant, upon records
to be maintained by the Company for that purpose (the “Warrant Register”), in the
name of the record Holder hereof from time to time.  The Company may
deem and treat the registered Holder of this Warrant as the absolute owner
hereof for the purpose of any exercise hereof or any distribution to the Holder,
and for all other purposes, absent actual notice to the contrary.

     

    
      
        
        

      

      
        1

        
          

        

      

      
        
        

      

    

     

    3. Registration of
Transfers.  The Company shall register the transfer of any
portion of this Warrant in the Warrant Register, upon surrender of this Warrant,
with the Form of Assignment attached hereto duly completed and signed, to the
Company at its address specified herein.  Upon any such registration
or transfer, a new warrant to purchase Common Stock, in substantially the form
of this Warrant (any such new warrant, a “New Warrant”), evidencing the
portion of this Warrant so transferred shall be issued to the transferee and a
New Warrant evidencing the remaining portion of this Warrant not so transferred,
if any, shall be issued to the transferring Holder.  The acceptance of
the New Warrant by the transferee thereof shall be deemed the acceptance by such
transferee of all of the rights and obligations of a holder of a
Warrant.

     

    4. Exercise and Duration of
Warrants.

     

    (a) This
Warrant shall be exercisable by the registered Holder at any time and from time
to time on or after the date hereof to and including the Expiration
Date.  At 5:00 P.M., New York City time on the Expiration Date, the
portion of this Warrant not exercised prior thereto shall be and become void and
of no value.

     

    (b) A Holder
may exercise this Warrant by delivering to the Company (i) an exercise notice,
in the form attached hereto (the “Exercise Notice”),
appropriately completed and duly signed, and (ii) payment of the Exercise
Price for the number of Warrant Shares as to which this Warrant is being
exercised, and the date such items are delivered to the Company (as determined
in accordance with the notice provisions hereof) is an “Exercise Date.”  The
Exercise Price may be paid by certified or bank check or wire transfer in
immediately available funds.  The Holder shall not be required to
deliver the original Warrant in order to effect an exercise
hereunder.  Execution and delivery of the Exercise Notice shall have
the same effect as cancellation of the original Warrant and issuance of a New
Warrant evidencing the right to purchase the remaining number of Warrant
Shares.

     

    5. Delivery of Warrant
Shares.

     

    (a) Upon
exercise of this Warrant, the Company shall promptly issue or cause to be issued
and cause to be delivered to or upon the written order of the Holder and in such
name or names as the Holder may designate, a certificate for the Warrant Shares
issuable upon such exercise, free of restrictive legends unless a registration
statement covering the resale of the Warrant Shares and naming the Holder as a
selling shareholder thereunder is not then effective and the Warrant Shares are
not freely transferable without volume restrictions pursuant to Rule 144 under
the Securities Act.  The Holder, or any Person (as hereinafter
defined) so designated by the Holder to receive Warrant Shares, shall be deemed
to have become holder of record of such Warrant Shares as of the Exercise
Date.  For purposes of this Warrant, the term “Person” means any individual
or corporation, partnership, trust, incorporated or unincorporated association,
joint venture, limited liability company, joint stock company, government (or an
agency or subdivision thereof) or any court or other federal, state, local or
other governmental authority or other entity of any kind.

     

    (b) This
Warrant is exercisable, either in its entirety or, from time to time, for a
portion of the number of Warrant Shares.  Upon surrender of this
Warrant following one or more partial exercises, the Company shall issue or
cause to be issued, at its expense, a New Warrant evidencing the right to
purchase the remaining number of Warrant Shares.

     

    
      
        
        

      

      
        2

        
          

        

      

      
        
        

      

    

     

    (c) The
Company’s obligations to issue and deliver Warrant Shares in accordance with the
terms hereof are absolute and unconditional, irrespective of any action or
inaction by the Holder to enforce the same, any waiver or consent with respect
to any provision hereof, the recovery of any judgment against any Person or any
action to enforce the same, or any setoff, counterclaim, recoupment, limitation
or termination, or any breach or alleged breach by the Holder or any other
Person of any obligation to the Company or any violation or alleged violation of
law by the Holder or any other Person, and irrespective of any other
circumstance which might otherwise limit such obligation of the Company to the
Holder in connection with the issuance of Warrant Shares.  Nothing
herein shall limit a Holder’s right to pursue any other remedies available to it
hereunder, at law or in equity including, without limitation, a decree of
specific performance and/or injunctive relief with respect to the Company’s
failure to timely deliver certificates representing shares of Common Stock upon
exercise of the Warrant as required pursuant to the terms hereof.

     

    6. Charges, Taxes and
Expenses.   Issuance and delivery of certificates for
shares of Common Stock upon exercise of this Warrant shall be made without
charge to the Holder for any issue or transfer tax, withholding tax, transfer
agent fee or other incidental tax or expense in respect of the issuance of such
certificates, all of which taxes and expenses shall be paid by the Company;
provided, however, that the Company shall not be required to pay any tax which
may be payable in respect of any transfer involved in the registration of any
certificates for Warrant Shares or Warrants in a name other than that of the
Holder or an Affiliate thereof.  The Holder shall be responsible for
all other tax liability that may arise as a result of holding or transferring
this Warrant or receiving Warrant Shares upon exercise hereof.

     

    7. Replacement of
Warrant.  If this Warrant is mutilated, lost, stolen or
destroyed, the Company shall issue or cause to be issued in exchange and
substitution for and upon cancellation hereof, or in lieu of and substitution
for this Warrant, a New Warrant, but only upon receipt of evidence reasonably
satisfactory to the Company of such loss, theft or destruction and customary and
reasonable bond or indemnity, if requested.  Applicants for a New
Warrant under such circumstances shall also comply with such other reasonable
regulations and procedures and pay such other reasonable third-party costs as
the Company may prescribe.

     

    8. Reservation of Warrant
Shares.  The Company covenants that it will at all times
reserve and keep available out of the aggregate of its authorized but unissued
and otherwise unreserved Common Stock, solely for the purpose of enabling it to
issue Warrant Shares upon exercise of this Warrant as herein provided, the
number of Warrant Shares which are then issuable and deliverable upon the
exercise of this entire Warrant, free from preemptive rights or any other
contingent purchase rights of persons other than the Holder (after giving effect
to the adjustments and restrictions of Section 9, if any).
The Company covenants that all Warrant Shares so issuable and deliverable shall,
upon issuance and the payment of the applicable Exercise Price in accordance
with the terms hereof, be duly and validly authorized, issued and fully paid and
nonassessable.  The Company will take all such action as may be
necessary to assure that such shares of Common Stock may be issued as provided
herein without violation of any applicable law or regulation, or of any
requirements of any securities exchange or automated quotation system upon which
the Common Stock may be listed.

     

    
      
        
        

      

      
        3

        
          

        

      

      
        
        

      

    

     

    9. Certain
Adjustments.  The Exercise Price and number of Warrant Shares
issuable upon exercise of this Warrant are subject to adjustment from time to
time as set forth in this Section
9.

     

    (a) Stock Dividends and
Splits.  If the Company, at any time while this Warrant is
outstanding, (i) pays a stock dividend on its Common Stock or otherwise makes a
distribution on any class of capital stock that is payable in shares of Common
Stock, (ii) subdivides outstanding shares of Common Stock into a larger number
of shares, or (iii) combines outstanding shares of Common Stock into a smaller
number of shares, then in each such case the Exercise Price shall be multiplied
by a fraction of which the numerator shall be the number of shares of Common
Stock outstanding immediately before such event and of which the denominator
shall be the number of shares of Common Stock outstanding immediately after such
event.  Any adjustment made pursuant to clause (i) of this paragraph
shall become effective immediately after the record date for the determination
of shareholders entitled to receive such dividend or distribution, and any
adjustment pursuant to clause (ii) or (iii) of this paragraph shall become
effective immediately after the effective date of such subdivision or
combination.

     

    (b) Fundamental
Transactions.  If, at any time while this Warrant is
outstanding, (i) the Company effects any merger or consolidation of the Company
with or into another Person, (ii) the Company effects any sale of all or
substantially all of its assets in one or a series of related transactions,
(iii) any tender offer or exchange offer (whether by the Company or another
Person) is completed pursuant to which holders of Common Stock are permitted to
tender or exchange their shares for other securities, cash or property, or (iv)
the Company effects any reclassification of the Common Stock or any compulsory
share exchange pursuant to which the Common Stock is effectively converted into
or exchanged for other securities, cash or property (other than as a result of a
subdivision or combination of shares of Common Stock covered by Section 9(a)
above) (in any such case, a “Fundamental Transaction”),
then the Holder shall have the right thereafter to receive, upon exercise of
this Warrant, the same amount and kind of securities, cash or property as it
would have been entitled to receive upon the occurrence of such Fundamental
Transaction if it had been, immediately prior to such Fundamental Transaction,
the holder of the number of Warrant Shares then issuable upon exercise in full
of this Warrant (the “Alternate
Consideration”).  The aggregate Exercise Price for this Warrant
will not be affected by any such Fundamental Transaction, but the Company shall
apportion such aggregate Exercise Price among the Alternate Consideration in a
reasonable manner reflecting the relative value of any different components of
the Alternate Consideration.  If holders of Common Stock are given any
choice as to the securities, cash or property to be received in a Fundamental
Transaction, then the Holder shall be given the same choice as to the Alternate
Consideration it receives upon any exercise of this Warrant following such
Fundamental Transaction.  At the Holder’s request, any successor to
the Company or surviving entity in such Fundamental Transaction shall issue to
the Holder a new warrant consistent with the foregoing provisions and evidencing
the Holder’s right to purchase the Alternate Consideration for the aggregate
Exercise Price upon exercise thereof.  The terms of any agreement
pursuant to which a Fundamental Transaction is effected shall include terms
requiring any such successor or surviving entity to comply with the provisions
of this paragraph (b) and insuring that the Warrant (or any such replacement
security) will be similarly adjusted upon any subsequent transaction analogous
to a Fundamental Transaction.

     

    
      
        
        

      

      
        4

        
          

        

      

      
        
        

      

    

     

    (c) Subsequent Equity
Sales.

     

    (i) If the
Company or any Subsidiary issues additional shares of Common Stock or rights,
warrants, options or other securities or debt convertible, exercisable or
exchangeable for shares of Common Stock or otherwise entitling any Person to
acquire shares of Common Stock (collectively, “Common Stock Equivalents”) at
an effective price yielding gross proceeds to the Company per share of Common
Stock (the “Effective
Price”) less than the Exercise Price (as adjusted hereunder), then the
Exercise Price shall be reduced to equal the product of (A) the Exercise Price
in effect immediately prior to such issuance of Common Stock or Common Stock
Equivalents times (B) a fraction, the numerator of which is the sum of (1) the
number of shares of Common Stock outstanding immediately prior to such issuance,
plus (2) the number of shares of Common Stock which the aggregate Effective
Price of the Common Stock issued (or deemed to be issued) would purchase at the
Exercise Price, and the denominator of which is the aggregate number of shares
of Common Stock outstanding or deemed to be outstanding immediately after such
issuance.  For purposes of this paragraph, in connection with any
issuance of any Common Stock Equivalents, (A) the maximum number of shares of
Common Stock potentially issuable at any time upon conversion, exercise or
exchange of such Common Stock Equivalents (the “Deemed Number”) shall be
deemed to be outstanding upon issuance of such Common Stock Equivalents, (B) the
Effective Price applicable to such Common Stock shall equal the minimum dollar
value of consideration payable to the Company to purchase such Common Stock
Equivalents and to convert, exercise or exchange them into Common Stock (net of
any discounts, fees, commissions and other expenses), divided by the Deemed
Number, and (C) no further adjustment shall be made to the Exercise Price upon
the actual issuance of Common Stock upon conversion, exercise or exchange of
such Common Stock Equivalents.

     

    (ii) If, at
any time while this Warrant is outstanding, the Company or any Subsidiary issues
Common Stock Equivalents with an Effective Price or a number of underlying
shares that floats or resets or otherwise varies or is subject to adjustment
based (directly or indirectly) on market prices of the Common Stock (a “Floating Price Security”),
then for purposes of applying the preceding paragraph in connection with any
subsequent exercise, the Effective Price will be determined separately on each
Exercise Date and will be deemed to equal the lowest Effective Price at which
any holder of such Floating Price Security is entitled to acquire Common Stock
on such Exercise Date (regardless of whether any such holder actually acquires
any shares on such date).

     

    (iii) Notwithstanding
the foregoing, no adjustment will be made under this paragraph (c) in respect to
any issuance of Common Stock (A) upon the exercise or conversion of any options,
warrants or debentures issued and outstanding as of the date of this Warrant,
(B) upon the exercise or conversion of any other Warrants, whether or not
outstanding as of the date of this Warrant, or (C) in connection with any
issuance of shares or grant of options to employees, officers, directors or
consultants of the Company pursuant to a stock option plan or other stock
incentive plan duly adopted by the Company’s board of directors and approved by
its shareholders, or (D) the issuance of up to a total of 75,000 shares of
Common Stock and Common Stock Equivalents in transactions and to persons other
than those described in the preceding clauses (A), (B) and (C).

     

    
      
        
        

      

      
        5

        
          

        

      

      
        
        

      

    

     

    (d) Number of Warrant
Shares.  Simultaneously with any adjustment to the Exercise
Price pursuant to paragraphs (a) or (c) of this Section, the number of Warrant
Shares that may be purchased upon exercise of this Warrant shall be increased or
decreased proportionately, so that after such adjustment the aggregate Exercise
Price payable hereunder for the increased or decreased number of Warrant Shares
shall be the same as the aggregate Exercise Price in effect immediately prior to
such adjustment.

     

    (e) Calculations.  All
calculations under this Section 9 shall be
made to the nearest cent or the nearest 1/100th of a share, as
applicable.  The number of shares of Common Stock outstanding at any
given time shall not include shares owned or held by or for the account of the
Company, and the disposition of any such shares shall be considered an issue or
sale of Common Stock.

     

    (f) Notice of
Adjustments.  Upon the occurrence of each adjustment pursuant
to this Section
9, the Company at its expense will promptly compute such adjustment in
accordance with the terms of this Warrant and prepare a certificate setting
forth such adjustment, including a statement of the adjusted Exercise Price and
adjusted number or type of Warrant Shares or other securities issuable upon
exercise of this Warrant (as applicable), describing the transactions giving
rise to such adjustments and showing in detail the facts upon which such
adjustment is based.  Upon written request, the Company will promptly
deliver a copy of each such certificate to the Holder and to the Company’s
Transfer Agent.

     

    (g) Notice of Corporate
Events.  If the Company (i) declares a dividend or any other
distribution of cash, securities or other property in respect of its Common
Stock, including without limitation any granting of rights or warrants to
subscribe for or purchase any capital stock of the Company or any Subsidiary,
(ii) authorizes or approves, enters into any agreement contemplating or solicits
shareholder approval for any Fundamental Transaction or (iii) authorizes the
voluntary dissolution, liquidation or winding up of the affairs of the Company,
then the Company shall deliver to the Holder a notice describing the material
terms and conditions of such transaction, at least 20 calendar days prior to the
applicable record or effective date on which a Person would need to hold Common
Stock in order to participate in or vote with respect to such transaction, and
the Company will take all steps reasonably necessary in order to insure that the
Holder is given the practical opportunity to exercise this Warrant prior to such
time so as to participate in or vote with respect to such transaction; provided,
however, that the failure to deliver such notice or any defect therein shall not
affect the validity of the corporate action required to be described in such
notice.

     

    10. Fractional
Shares.  The Company shall not be required to issue or cause to
be issued fractional Warrant Shares on the exercise of this
Warrant.  If any fraction of a Warrant Share would, except for the
provisions of this Section, be issuable upon exercise of this Warrant, the
number of Warrant Shares to be issued will be rounded up to the nearest whole
share.

     

    
      
        
        

      

      
        6

        
          

        

      

      
        
        

      

       

       

    

    11. Notices.  Any
and all notices or other communications or deliveries hereunder (including
without limitation any Exercise Notice) shall be in writing and shall be deemed
given and effective on the earliest of (i) the date of transmission, if such
notice or communication is delivered via facsimile at the facsimile number
specified in this Section prior to 5:00 p.m. (New York City time) on any day on
which trading occurs on the Nasdaq Stock Market (or any successor thereto) (a
“Trading Day”), (ii) the
next Trading Day after the date of transmission, if such notice or communication
is delivered via facsimile at the facsimile number specified in this Section on
a day that is not a Trading Day or later than 5:00 p.m. (New York City time) on
any Trading Day, (iii) the Trading Day following the date of mailing, if sent by
nationally recognized overnight courier service, or (iv) upon actual receipt by
the party to whom such notice is required to be given.  The address
for such notices or communications shall be as set forth in the Purchase
Agreement.

     

    12. Warrant
Agent.  The Company shall serve as warrant agent under this
Warrant.  Upon 30 days’ notice to the Holder, the Company may appoint
a new warrant agent.  Any corporation into which the Company or any
new warrant agent may be merged or any corporation resulting from any
consolidation to which the Company or any new warrant agent shall be a party or
any corporation to which the Company or any new warrant agent transfers
substantially all of its corporate trust or shareholders services business shall
be a successor warrant agent under this Warrant without any further
act.  Any such successor warrant agent shall promptly cause notice of
its succession as warrant agent to be mailed (by first class mail, postage
prepaid) to the Holder at the Holder's last address as shown on the Warrant
Register.

     

    13. Miscellaneous.

     

    (a) Subject
to the restrictions on transfer set forth on the first page hereof, this Warrant
may be assigned by the Holder.  This Warrant may not be assigned by
the Company except to a successor in the event of a Fundamental
Transaction.  This Warrant shall be binding on and inure to the
benefit of the parties hereto and their respective successors and
assigns.  Subject to the preceding sentence, nothing in this Warrant
shall be construed to give to any Person other than the Company and the Holder
any legal or equitable right, remedy or cause of action under this
Warrant.  This Warrant may be amended only in writing signed by the
Company and the Holder and their successors and assigns.

     

    (b) The
Company will not, by amendment of its governing documents or through any
reorganization, transfer of assets, consolidation, merger, dissolution, issue or
sale of securities or any other voluntary action, avoid or seek to avoid the
observance or performance of any of the terms of this Warrant, but will at all
times in good faith assist in the carrying out of all such terms and in the
taking of all such action as may be necessary or appropriate in order to protect
the rights of the Holder against impairment.  Without limiting the
generality of the foregoing, the Company (i) will not increase the par value of
any Warrant Shares above the amount payable therefor on such exercise, (ii) will
take all such action as may be reasonably necessary or appropriate in order that
the Company may validly and legally issue fully paid and nonassessable Warrant
Shares on the exercise of this Warrant, and (iii) will not close its shareholder
books or records in any manner which interferes with the timely exercise of this
Warrant.

     

    
      
        
        

      

      
        7

        
          

        

      

      
        
        

      

       

       

    

    (c) Governing Law; Venue; Waiver
Of Jury Trial.  all questions concerning the construction,
validity, enforcement and interpretation of this warrant shall be governed by
and construed and enforced in accordance with the laws of the state of new
york.  each party hereby irrevocably submits to the exclusive
jurisdiction of the state and federal courts sitting in the city of new york,
borough of manhattan, for the adjudication of any dispute hereunder, and hereby
irrevocably waives, and agrees not to assert in any suit, action or proceeding,
any claim that it is not personally subject to the jurisdiction of any such
court, that such suit, action or proceeding is improper.  each party
hereby irrevocably waives personal service of process and consents to process
being served in any such suit, action or proceeding by mailing a copy thereof
via registered or certified mail or overnight delivery (with evidence of
delivery) to such party at the address in effect for notices to it under this
agreement and agrees that such service shall constitute good and sufficient
service of process and notice thereof. nothing contained herein shall be deemed
to limit in any way any right to serve process in any manner permitted by
law.  the company hereby waives all rights to a trial by
jury.

     

    (d) The
headings herein are for convenience only, do not constitute a part of this
Warrant and shall not be deemed to limit or affect any of the provisions
hereof.

     

    (e) In case
any one or more of the provisions of this Warrant shall be invalid or
unenforceable in any respect, the validity and enforceability of the remaining
terms and provisions of this Warrant shall not in any way be affected or
impaired thereby and the parties will attempt in good faith to agree upon a
valid and enforceable provision which shall be a commercially reasonable
substitute therefor, and upon so agreeing, shall incorporate such substitute
provision in this Warrant.

     

    SIGNATURE
PAGE FOLLOWS

     

    
      
        
        

      

      
        8

        
          

        

      

      
        
        

      

    

    IN
WITNESS WHEREOF, the Company has caused this Warrant to be duly executed by its
authorized officer as of the date first indicated above.

     

    
      	 
      
	
              CYBRA
      CORPORATION

            
	 
      
	 
      
	
              By:                                                                

            
	
              Name:  Harold
      Brand

            
	
              Title:    President
      and Chief Executive Officer

            

    

     

    
      
        
        

      

      
        9

        
          

        

      

      
        
        

      

    

     

    FORM OF
EXERCISE NOTICE

     

    (To be
executed by the Holder to exercise the right to purchase shares of Common Stock
under the foregoing Warrant)

     

    To:  CYBRA
CORPORATION

     

    The
undersigned is the Holder of Warrant No. _______ (the “Warrant”) issued by CYBRA
Corporation, a New York corporation (the “Company”).  Capitalized
terms used herein and not otherwise defined have the respective meanings set
forth in the Warrant.

     

    
      	
              1.  

            	
              The
      Warrant is currently exercisable to purchase a total of ______________
      Warrant Shares.

            

    

     

    
      	
              2.  

            	
              The
      undersigned Holder hereby exercises its right to purchase
      _________________ Warrant Shares pursuant to the
  Warrant.

            

    

     

    
      	
              3.  

            	
              The
      holder shall pay the sum of $____________ to the Company in accordance
      with the terms of the Warrant.

            

    

     

    
      	
              4.  

            	
              Pursuant
      to this exercise, the Company shall deliver to the holder _______________
      Warrant Shares in accordance with the terms of the
  Warrant.

            

    

     

    
      	
              5.  

            	
              Following
      this exercise, the Warrant shall be exercisable to purchase a total of
      ______________ Warrant Shares.

            

    

     

    
      	 
      	 
      	 
      
	 
      	 
      	 
      
	
              Dated:                                      ,

            	 
      	
              Name
      of Holder:

            
	 
      	 
      	 
      
	 
      	 
      	
              (Print)                                                             

            
	 
      	 
      	 
      
	 
      	 
      	
              By:                                                             

            
	 
      	 
      	
              Name:                                                             

            
	 
      	 
      	
              Title:                                                             

            
	 
      	 
      	 
      
	 
      	 
      	
              (Signature
      must conform in all respects to name of holder as specified on the face of
      the Warrant)

            

    

     

     

    
      
        
        

      

      
        10

        
          

        

      

      
        
        

      

    

     

    FORM OF
ASSIGNMENT

     

    [To be
completed and signed only upon transfer of Warrant]

     

    FOR VALUE
RECEIVED, the undersigned hereby sells, assigns and transfers unto
________________________________ the right represented by the within Warrant to
purchase  ____________ shares of Common Stock of CYBRA Corporation to
which the within Warrant relates and appoints ________________ attorney to
transfer said right on the books of CYBRA Corporation with full power of
substitution in the premises.

     

    
      	 
      	 
      
	 
      	 
      
	
              Dated:                                      ,

            	 
      
	 
      	 
      
	 
      	 
      
	 
      	
              (Signature
      must conform in all respects to name of holder as specified on the face of
      the Warrant)

            
	 
      	 
      
	 
      	 
      
	 
      	
              Address
      of Transferee

            
	 
      	 
      
	 
      	 
      
	 
      	 
      
	 
      	 
      
	 
      	 
      
	 
      	 
      
	
              In
      the presence of:

            	 
      
	 
      	 
      
	 
      	 
      
	 
      	 
      

    

    

     

    

    11EX-10.1

FIRST AMENDMENT AGREEMENT

This FIRST AMENDMENT AGREEMENT (this “Amendment”) is made as of the 31st day of
March, 2009 among:

(a) CORE MOLDING TECHNOLOGIES, INC., a Delaware corporation (“Core Molding”);

(b) CORECOMPOSITES DE MEXICO, S. DE R.L. DE C.V., a sociedad de responsabilidad limitada de
capital variable organized under the laws of Mexico (“Core Mexico” and, together with Core Molding,
collectively, “Borrowers” and, individually, each a “Borrower”);

(c) the Lenders, as defined in the Credit Agreement, as hereinafter defined; and

(d) KEYBANK NATIONAL ASSOCIATION, as the lead arranger, sole book runner and administrative
agent for the Lenders under the Credit Agreement (“Agent”).

WHEREAS, Borrowers, Agent and the Lenders are parties to that certain Credit Agreement, dated
as of December 9, 2008, that provides, among other things, for loans and letters of credit
aggregating Thirty-Four Million Eleven Thousand Fifty-Six and 15/100 Dollars ($34,011,056.15), all
upon certain terms and conditions (as the same may from time to time be amended, restated or
otherwise modified, the “Credit Agreement”);

WHEREAS, Borrowers, Agent and the Lenders desire to amend the Credit Agreement to modify
certain provisions thereof and add certain provisions thereto;

WHEREAS, each capitalized term used herein and defined in the Credit Agreement, but not
otherwise defined herein, shall have the meaning given such term in the Credit Agreement; and

WHEREAS, unless otherwise specifically provided herein, the provisions of the Credit Agreement
revised herein are amended effective as of the date of this Amendment;

NOW, THEREFORE, in consideration of the premises and of the mutual covenants herein and for
other valuable consideration, Borrowers, Agent and the Lenders agree as follows:

1. Amendment to Definitions. Section 1.1 of the Credit Agreement is hereby amended to
delete the definitions of “Applicable Margin”, “Base Rate”, “Commitment Period”, “Consolidated
EBITDA”, “Consolidated Fixed Charges”, “Daily LIBOR Rate”, “Eurodollar Rate”, “Mexican Line
Conversion Date” and “Project Completion Date” therefrom and to insert in place thereof,
respectively, the following:

“Applicable Margin” means:

(a) for the period from the Closing Date through March 30, 2009, (i) one
hundred seventy-five (175.00) basis points for Eurodollar Loans, (ii) one hundred
seventy-five (175.00) basis points for Daily LIBOR Loans, and (iii) zero (0.00)
basis points for Base Rate Loans;

(b) for the period from March 31, 2009 through August 31, 2009, (i) four
hundred (400.00) basis points for Eurodollar Loans, (ii) four hundred (400.00) basis
points for Daily LIBOR Loans, and (iii) three hundred (300.00) basis points for Base
Rate Loans; and

(c) commencing with the Consolidated financial statements of Core Molding for
the fiscal quarter ending June 30, 2009, the number of basis points (depending upon
whether Loans are Eurodollar Loans, Daily LIBOR Loans or Base Rate Loans) set forth
in the following matrix, based upon the result of the computation of the Leverage
Ratio as set forth in the Compliance Certificate for such fiscal period, shall be
used to establish the number of basis points that will go into effect on September
1, 2009 and, thereafter, as set forth in each successive Compliance Certificate, as
provided below:

	 	 	 	 	 	 	 
	 	 	Applicable Basis	 	Applicable Basis	 	Applicable Basis
	 	 	Points for Daily	 	Points for	 	Points for
	Leverage Ratio	 	LIBOR Loans	 	Eurodollar Loans	 	Base Rate Loans
	Greater than 2.25

to 1.00

	 	

400.00
	 	

400.00
	 	

300.00
	 

	 	 
	 	 
	 	 
	Less than or equal

to 2.25 to 1.00

	 	

375.00
	 	

375.00
	 	

275.00
	 

	 	 
	 	 
	 	 

After September 1, 2009, changes to the Applicable Margin shall be effective on the
first day of each fiscal quarter following the date upon which Agent should have
received, pursuant to Section 5.3(a) hereof, the Consolidated financial statements
of Core Molding (provided that, if the internal financial statements required by
Section 5.3(a) hereof are not consistent with the audited financial statements
required by Section 5.3(b) hereof, the Applicable Margin shall be retroactively
adjusted upon receipt of the audited statements). The above matrix does not modify
or waive, in any respect, the requirements of Section 5.7 hereof, the rights of
Agent and the Lenders to charge the Default Rate, or the rights and remedies of
Agent and the Lenders pursuant to Articles VII and VIII hereof. Notwithstanding
anything herein to the contrary, (i) during any period when Borrowers shall have
failed to timely deliver the Consolidated financial statements pursuant to Section
5.3(a) or (b) hereof, or the Compliance Certificate pursuant to Section 5.3(c)
hereof, until such time as the appropriate Consolidated financial statements and
Compliance Certificate are delivered, the Applicable Margin shall be the highest
rate per annum indicated in the above pricing grid for Loans of that type regardless
of the Leverage Ratio at such time, and (ii) in the event that any financial
information or certification provided to Agent in the Compliance Certificate is
shown to be inaccurate (regardless of whether this Agreement or the Commitment is in
effect when such inaccuracy is discovered), and such inaccuracy, if corrected, would
have led to the application of a higher Applicable Margin for any period (an
“Applicable Margin Period”) than the Applicable Margin applied for such Applicable
Margin Period, then (A) Borrowers shall immediately deliver to Agent a corrected
Compliance Certificate for such Applicable Margin Period, (B) the Applicable Margin
shall be determined based on such corrected Compliance Certificate, and (C)
Borrowers shall immediately pay to Agent the accrued additional interest owing as a
result of such increased Applicable Margin for such Applicable Margin Period.

“Base Rate” means:

(a) other than as set forth in subsection (b) below, a rate per annum equal to
the highest of (i) the Prime Rate, (ii) one-half of one percent (.50%) in excess of
the Federal Funds Effective Rate, or (iii) two percent (2%) in excess of the
Eurodollar Rate for loans with an Interest Period of one month; and

(b) with respect to the Mexican Loan, a rate per annum equal to the higher of
(i) the prime rate reported in The Wall Street Journal (or the average prime rate if
a high and a low prime rate are reported therein), or (ii) two percent (2%) in
excess of the Daily LIBOR Rate applicable to the Mexican Loan.

“Commitment Period” means (a) with respect to the Revolving Credit Commitment, the
period from the Closing Date to April 30, 2010, (b) with respect to the Capex Draw
Commitment, the period from the Closing Date to the Capex Conversion Date, (c) with respect
to the Mexican Loan Commitment, the period from the Closing Date to the Mexican Line
Conversion Date, and (d) with respect to the IDRB Letter of Credit Commitment, the period
from the Closing Date to April 17, 2014, or, in the case of each (a), (b), (c) and (d), such
earlier date on which the Commitment shall have been terminated pursuant to Article VIII
hereof.

“Consolidated EBITDA” means, for any period, as determined on a Consolidated basis and
in accordance with GAAP, (a) Consolidated Net Earnings for such period plus, without
duplication, the aggregate amounts deducted in determining such Consolidated Net Earnings in
respect of (i) Consolidated Interest Expense, (ii) Consolidated Income Tax Expense,
(iii) Consolidated Depreciation and Amortization Charges, (iv) reasonable non-recurring
non-cash losses not incurred in the ordinary course of business, (v) non-cash compensation
expenses recognized under Statement of Financial Accounting Standards 123R in connection
with Core Molding’s equity incentive stock option plan and restricted stock grants; and (vi)
transition and relocation costs incurred in construction of the Mexican Project (up to an
aggregate amount not to exceed Three Million Two Hundred Thousand Dollars ($3,200,000) from
September 1, 2008 through July 31, 2009); minus, (b) to the extent included in Consolidated
Net Earnings for such period, non-recurring gains not incurred in the ordinary course of
business.

“Consolidated Fixed Charges” means, for any period, on a Consolidated basis and in
accordance with GAAP, the aggregate, without duplication, of (a) Consolidated Interest
Expense (including, without limitation, the “imputed interest” portion of Capitalized Lease
Obligations, synthetic leases and asset securitizations, if any, but excluding any measure
of ineffectiveness related to interest rate swaps and amortization of loan origination and
issuance costs), (b) Consolidated Income Tax Expense, (c) scheduled principal payments of
long-term Consolidated Funded Indebtedness (other than scheduled principal payments of the
Mexican Loan that were prepaid by Core Molding or any of its Subsidiaries one year (or
longer) prior to the due date of such principal payment), (d) Capital Distributions, and (e)
Consolidated Unfunded Capital Expenditures; provided that, for the purposes of calculating
the Fixed Charge Coverage Ratio, on and after the Capital Expenditure Modification Date,
Consolidated Unfunded Capital Expenditures shall be deemed to be Two Million Dollars
($2,000,000) for the most recently completed four fiscal quarters of Core Molding.

“Daily LIBOR Rate” means, for any Daily Interest Period:

(a) with respect to a Daily LIBOR Loan that is a Revolving Loan or a Swing
Loan, a rate per annum equal to the greater of (i) the per annum rate of interest
(rounded upwards, if necessary, to the nearest 1/16th of 1%) at which,
determined by Agent in accordance with its usual procedures (which determination
shall be conclusive absent manifest error) as of approximately 11:00 A.M. (London
time) two Business Days prior to the beginning of such Daily Interest Period, Dollar
deposits in immediately available funds in an amount comparable to such Loan and
with a maturity of one day are offered to the prime banks by leading banks in the
London interbank market, and (ii) one and one-half percent (1.50%); and

(b) with respect to a Daily LIBOR Loan that is the Mexican Loan, a rate per
annum equal to the greater of (i) the per annum the rate of interest, as of
approximately 11:00 A.M. (London time) two Business Days prior to such date as the
rate in the London interbank market for Dollar deposits in immediately available
funds in an amount comparable to such Loan and with a maturity of one day are
offered to the prime banks by leading banks in the London interbank market, and (ii)
one and one-half percent (1.50%).

“Eurodollar Rate” means, with respect to a Eurodollar Loan, for any Interest Period, a
rate per annum equal to the greater of (a) the quotient obtained by dividing (i) the rate of
interest, determined by Agent in accordance with its usual procedures (which determination
shall be conclusive absent manifest error) as of approximately 11:00 A.M. (London time) two
Business Days prior to the beginning of such Interest Period pertaining to such Eurodollar
Loan, as listed on British Bankers Association Interest Rate LIBOR 01 or 02 as provided by
Reuters or Bloomberg (or, if for any reason such rate is unavailable from Reuters or
Bloomberg, from any other similar company or service that provides rate quotations
comparable to those currently provided by Reuters or Bloomberg) as the rate in the London
interbank market for Dollar deposits in immediately available funds with a maturity
comparable to such Interest Period, provided that, in the event that such rate quotation is
not available for any reason, then the Eurodollar Rate shall be the average of the per annum
rates at which deposits in immediately available funds in Dollars for the relevant Interest
Period and in the amount of the Eurodollar Loan to be disbursed or to remain outstanding
during such Interest Period, as the case may be, are offered to Agent (or an affiliate of
Agent, in Agent’s discretion) by prime banks in any Eurodollar market reasonably selected by
Agent, determined as of 11:00 A.M. (London time) (or as soon thereafter as practicable), two
Business Days prior to the beginning of the relevant Interest Period pertaining to such
Eurodollar Loan; by (ii) 1.00 minus the Reserve Percentage, and (b) one and one-half percent
(1.50%).

“Mexican Line Conversion Date” means August 15, 2009.

“Project Completion Date” means August 15, 2009, subject to extension pursuant to
Section 5.28(a) hereof.

2. Amendment to Permitted Foreign Subsidiary Loans and Investments Definition. The
Permitted Foreign Subsidiary Loans and Investments definition is hereby amended to delete subpart
(d) therefrom and to insert in place thereof the following:

(d) any investment or loan by Core Molding or a Domestic Subsidiary in or to, or
guaranty (excluding the guaranty set forth in Article X hereof) from Core Molding or a
Domestic Subsidiary of Indebtedness of, Core Mexico, made after the Closing Date, (i) for
the period from the Closing Date through December 31, 2009, up to the aggregate amount not
to exceed Twelve Million Dollars ($12,000,000) at any time outstanding, and (ii) in
addition, so long as Core Mexico shall have fully drawn the Mexican Loan prior to the
Mexican Line Conversion Date and the Mexican Loan is not prepaid (excluding scheduled
principal payments), during each fiscal year of Core Molding commencing after December 31,
2009, Core Molding may increase the aggregate amount outstanding by up to Three Million
Dollars ($3,000,000) per year;

3. Additions to Definitions. Article I of the Credit Agreement is hereby amended to
add the following new definitions thereto:

“First Amendment Effective Date” means March 31, 2009.

4. Amendment to IDRB Letter of Credit. Section 2.6(c) of the Credit Agreement is
hereby amended to delete subparts (i) and (ii) therefrom and to insert in place thereof,
respectively, the following:

(i) pay to Agent, for the pro rata benefit of the Lenders, a non-refundable letter of
credit fee from the Closing Date through the last day of the Commitment Period applicable to
the IDRB Letter of Credit, which shall be paid monthly in arrears, on each Regularly
Scheduled Payment Date, at a rate per annum equal to (A) (i) for the period from the Closing
Date through April 16, 2009, seventy-five (75.00) basis points, and (2) on April 17, 2009
and thereafter, three hundred (300.00) basis points, multiplied by (B) the IDRB Letter of
Credit Commitment, as such amount is reduced on a quarterly basis in accordance with the
terms of the IDRB Documents;

(ii) [Reserved]; and

5. Amendment to Interest. Section 2.7 of the Credit Agreement is hereby amended to
delete subsections (c) and (g) therefrom and to insert in place thereof, respectively, the
following:

(c) Term Loan.

(i) Base Rate Loan. With respect to any portion of the Term Loan that
is a Base Rate Loan, Core Molding shall pay interest on the unpaid principal amount
thereof outstanding from time to time from the date thereof until paid, commencing
April 1, 2009, and continuing on each Regularly Scheduled Payment Date thereafter
and at the maturity thereof, at a rate per annum equal to three hundred (300.00)
basis points in excess of the Base Rate from time to time in effect.

(ii) Eurodollar Loans. With respect to any portion of the Term Loan
that is a Eurodollar Loan, Core Molding shall pay interest on the unpaid principal
amount of such Eurodollar Loan outstanding from time to time, fixed in advance on
the first day of the Interest Period applicable thereto through the last day of the
Interest Period applicable thereto, at a rate per annum equal to four hundred
(400.00) basis points in excess of the Eurodollar Rate). Interest on such
Eurodollar Loan shall be payable on each Interest Adjustment Date with respect to an
Interest Period. Notwithstanding anything in this Agreement to the contrary, all
Eurodollar Loans that are a portion of the Term Loan shall have an Interest Period
of one month.

(g) [Reserved.]

6. Amendment to Post-Closing Conditions. Section 4.3 of the Credit Agreement is
hereby amended to delete subsection (d) therefrom and to insert in place thereof the following:

(d) Title Insurance for the Mexican Real Property. No later than April 13,
2009, with respect to the Mexican Real Property, Borrowers shall have delivered to Agent
copies of the title insurance, in form and substance satisfactory to Agent, obtained by Core
Mexico on the acquisition of the land for the Mexican Project and original insurance
certificate appointing Agent, for the benefit of the Lenders, as first loss payee
thereunder.

7. Amendment to Financial Covenants. Section 5.7 of the Credit Agreement is hereby
amended to delete subsection (a) therefrom and to insert in place thereof the following:

(a) Leverage Ratio. Borrowers shall not suffer or permit at any time the
Leverage Ratio to exceed (i) 3.00 to 1.00 on the Closing Date through June 29, 2009, (ii)
3.20 to 1.00 on June 30, 2009 through September 29, 2009, (iii) 3.40 to 1.00 on September
30, 2009 through December 30, 2009, (iv) 3.20 to 1.00 on December 31, 2009 through March 30,
2010, and (v) 3.00 to 1.00 on March 31, 2010 and thereafter.

8. Closing Deliveries. Concurrently with the execution of this Amendment, Borrowers
shall:

(a) execute and deliver to Agent, for its sole benefit, the First Amendment Agent Fee
Letter, and pay to Agent the fees stated therein;

(b) cause each Guarantor of Payment to execute the attached Guarantor Acknowledgement
and Agreement; and

(c) pay all legal fees and expenses of Agent in connection with this Amendment.

9. Representations and Warranties. Borrowers hereby represent and warrant to Agent
and the Lenders that (a) Borrowers have the legal power and authority to execute and deliver this
Amendment; (b) the officers executing this Amendment have been duly authorized to execute and
deliver the same and bind Borrowers with respect to the provisions hereof; (c) the execution and
delivery hereof by Borrowers and the performance and observance by Borrowers of the provisions
hereof do not violate or conflict with the Organizational Documents of Borrowers or any law
applicable to Borrowers or result in a breach of any provision of or constitute a default under any
other agreement, instrument or document binding upon or enforceable against Borrowers; (d) no
Default or Event of Default exists, nor will any occur immediately after the execution and delivery
of this Amendment or by the performance or observance of any provision hereof; (e) each of the
representations and warranties contained in the Loan Documents is true and correct in all material
respects as of the First Amendment Effective Date as if made on the First Amendment Effective Date,
except to the extent that any such representation or warranty expressly states that it relates to
an earlier date (in which case such representation or warranty is true an correct in all material
respects as of such earlier date); (f) Borrowers are not aware of any claim or offset against, or
defense or counterclaim to, Borrowers’ obligations or liabilities under the Credit Agreement or any
Related Writing; and (g) this Amendment constitutes a valid and binding obligation of Borrowers in
every respect, enforceable in accordance with its terms.

10. No Course of Dealing. Borrowers acknowledge and agree that this Amendment is not
intended, nor shall it, establish any course of dealing with respect to the various provisions
amended herein, or otherwise, among Borrowers, Agent and the Lenders that is inconsistent with the
express terms of the Loan Documents.

11. Waiver and Release. Borrowers, by signing below, hereby waive and release Agent
and each of the Lenders, and their respective directors, officers, employees, attorneys, affiliates
and subsidiaries, from any and all claims, offsets, defenses and counterclaims of which Borrowers
are aware, such waiver and release being with full knowledge and understanding of the circumstances
and effect thereof and after having consulted legal counsel with respect thereto.

12. References to Credit Agreement and Ratification. Each reference that is made in
the Credit Agreement or any other Related Writing shall hereafter be construed as a reference to
the Credit Agreement as amended hereby. Except as herein otherwise specifically provided, all terms
and provisions of the Credit Agreement are confirmed and ratified and shall remain in full force
and effect and be unaffected hereby. This Amendment is a Related Writing.

13. Counterparts. This Amendment may be executed in any number of counterparts, by
different parties hereto in separate counterparts and by facsimile signature, each of which, when
so executed and delivered, shall be deemed to be an original and all of which taken together shall
constitute but one and the same agreement.

14. Headings. The headings, captions and arrangements used in this Amendment are for
convenience only and shall not affect the interpretation of this Amendment.

15. Severability. Any term or provision of this Amendment held by a court of
competent jurisdiction to be invalid or unenforceable shall not impair or invalidate the remainder
of this Amendment and the effect thereof shall be confined to the term or provision so held to be
invalid or unenforceable.

16. Governing Law. The rights and obligations of all parties hereto shall be governed
by the laws of the State of Ohio, without regard to principles of conflicts of laws.

[Remainder of page intentionally left blank.]

11447982.8

JURY TRIAL WAIVER. BORROWERS, AGENT AND THE LENDERS, TO THE EXTENT
PERMITTED BY LAW, EACH HEREBY WAIVES ANY RIGHT TO HAVE A JURY PARTICIPATE IN RESOLVING ANY DISPUTE,
WHETHER SOUNDING IN CONTRACT, TORT OR OTHERWISE, AMONG BORROWERS, AGENT AND THE LENDERS, OR ANY
THEREOF, ARISING OUT OF, IN CONNECTION WITH, RELATED TO, OR INCIDENTAL TO THE RELATIONSHIP
ESTABLISHED AMONG THEM IN CONNECTION WITH THIS AMENDMENT OR ANY NOTE OR OTHER INSTRUMENT, DOCUMENT
OR AGREEMENT EXECUTED OR DELIVERED IN CONNECTION HEREWITH OR THE TRANSACTIONS RELATED THERETO.
THIS WAIVER SHALL NOT IN ANY WAY AFFECT, WAIVE, LIMIT, AMEND OR MODIFY AGENT’S OR ANY LENDER’S
ABILITY TO PURSUE REMEDIES PURSUANT TO ANY CONFESSION OF JUDGMENT OR COGNOVIT PROVISION CONTAINED
IN ANY NOTE OR OTHER INSTRUMENT, DOCUMENT OR AGREEMENT AMONG BORROWERS, AGENT AND THE LENDERS.

IN WITNESS WHEREOF, the parties have executed and delivered this Amendment in Columbus, Ohio
as of the date first set forth above.

	 
	CORE MOLDING TECHNOLOGIES, INC.
	By: /s/ Herman F. Dick, Jr.
	Name: Herman F. Dick, Jr.
	Title: Chief Financial Officer and Vice President
	CORECOMPOSITES DE MEXICO, S. DE R.L. DE C.V.
	By: /s/Herman F. Dick, Jr.
	Name: Herman F. Dick, Jr.
	Title:Attorney-in-fact
	KEYBANK NATIONAL ASSOCIATION,
	as Agent and as a Lender
	By: /s/ Roger D. Campbell
	Name:Roger D. Campbell
	Title: Senior Vice President

ACKNOWLEDGMENT AND AGREEMENT

The undersigned consent and agree to and acknowledge the terms of the foregoing First
Amendment Agreement dated as of March 31, 2009. The undersigned further agree that the obligations
of the undersigned pursuant to the Guaranty of Payment executed by the undersigned are hereby
ratified and shall remain in full force and effect and be unaffected hereby.

The undersigned hereby waive and release Agent and the Lenders and their respective directors,
officers, employees, attorneys, affiliates and subsidiaries from any and all claims, offsets,
defenses and counterclaims of any kind or nature, absolute and contingent, of which the undersigned
are aware or should be aware, such waiver and release being with full knowledge and understanding
of the circumstances and effect thereof and after having consulted legal counsel with respect
thereto.

JURY TRIAL WAIVER. THE UNDERSIGNED, TO THE EXTENT PERMITTED BY LAW, HEREBY WAIVE ANY
RIGHT TO HAVE A JURY PARTICIPATE IN RESOLVING ANY DISPUTE, WHETHER SOUNDING IN CONTRACT, TORT OR
OTHERWISE, AMONG BORROWERS, AGENT, THE LENDERS AND THE UNDERSIGNED, OR ANY THEREOF, ARISING OUT OF,
IN CONNECTION WITH, RELATED TO, OR INCIDENTAL TO THE RELATIONSHIP ESTABLISHED AMONG THEM IN
CONNECTION WITH THIS AMENDMENT OR ANY NOTE OR OTHER INSTRUMENT, DOCUMENT OR AGREEMENT EXECUTED OR
DELIVERED IN CONNECTION HEREWITH OR THE TRANSACTIONS RELATED THERETO. THIS WAIVER SHALL NOT IN ANY
WAY AFFECT, WAIVE, LIMIT, AMEND OR MODIFY THE ABILITY OF AGENT AND LENDERS TO PURSUE REMEDIES
PURSUANT TO ANY CONFESSION OF JUDGMENT OR COGNOVIT PROVISION CONTAINED IN ANY NOTE OR OTHER
INSTRUMENT, DOCUMENT OR AGREEMENT BETWEEN BORROWER, AGENT AND LENDERS.

	 	 	 
	CORE COMPOSITES CINCINNATI, LLC

By/ Herman F. Dick, Jr.
	 	CORE COMPOSITES CORPORATION

By: / Herman F. Dick, Jr.

	 
	 	 

	Name: Herman F. Dick, Jr.

Title: Chief Financial Officer and

Vice President
	 	Name: Herman F. Dick, Jr.

Title: Chief Financial Officer and Vice

President

	 	 	CORE AUTOMOTIVE TECHNOLOGIES

LLC

By: Core Molding Technologies, Inc.,

Its sole member

By/ Herman F. Dick, Jr.

	 	 	 

	 	 	Name: Herman F. Dick, Jr.

Title: Chief Financial Officer and Vice

President

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00157-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00157-of-00352.parquet"}]]